How generative AI and E. coli are speeding up new drug discovery

Check out all the on-demand sessions from the Intelligent Security Summit here. For many, hearing the word E. coli is often a reason to be concerned, as the bacteria can lead to incidents of food poisoning in humans. As it turns out, E. coli might well be the panacea that enables a new form of generative AI for healthcare that could help enable researchers to generate new antibodies. Generative AI in recent years has captured popular imagination by enabling users to generate text or images on demand, but its uses go much deeper, too. Generative models that provide large machine learning (ML) models that can create new things is an emerging area in science helping to accelerate discovery.